Questions first. Decisions later.

A hair transplant redistributes living follicular-unit grafts from a donor area—usually the back and sides of the scalp—to an area of hair loss. It does not create new follicles or cure the condition causing loss. The result depends on diagnosis, donor selection, design, graft handling, placement and long-term planning.

Common causes include androgenetic or pattern hair loss, telogen effluvium, alopecia areata, traction, inflammatory scarring alopecia, hormonal or nutritional problems, medicines, illness and physical damage. More than one process can occur at the same time, which is why a label based only on photographs may be wrong.

Different conditions can look similar but need very different care. History, scalp examination and magnification can identify miniaturisation, inflammation, scarring and donor instability; blood tests or a dermatology opinion may sometimes be needed. Surgery performed before the cause is understood can waste donor hair or operate into active disease.

Suitability usually requires a transplantable diagnosis, a healthy scalp, adequate stable donor hair, a medically safe procedure and realistic goals. Age, rate of loss, hair calibre, curl, colour contrast, previous surgery and the size of the area all matter. A responsible assessment may recommend treatment, observation, medical management or no surgery.

No. A transplant may be unsuitable when the donor is diffusely miniaturised or depleted, loss is rapidly changing, scalp disease is active, the requested coverage exceeds the available donor supply, or expectations cannot be met safely. Declining or postponing surgery can be the correct clinical recommendation.

There is no single age cut-off, but younger patients often have a less predictable future pattern and many decades of possible loss ahead. Early low or dense hairline work can consume donor needed later. Diagnosis, stability, maturity of the pattern and willingness to plan conservatively matter more than a birthday alone.

Alopecia areata is an immune-mediated condition and is not routinely treated by transplantation while active because transplanted follicles may also be affected. Diagnosis and disease control come first. Only exceptional, carefully selected stable cases should be considered after specialist review, with clear discussion of recurrence and uncertain growth.

Sometimes, but only after the diagnosis is secure and inflammatory activity has been inactive for an appropriate period under specialist care. Scarred skin has altered blood supply and graft survival can be less predictable. A small test session or staged approach may be sensible, and disease can still reactivate.

The plan should pause. Further photographs, serial review, blood tests, dermoscopy, biopsy or referral to a dermatologist may be appropriate depending on the findings. A sales deadline is never a substitute for diagnostic clarity, and no irreversible procedure should proceed merely because a graft number has already been quoted.

Confirm the exact treatment address—not only the company’s office—and check the regulator for that UK nation. In England, BAHRS advises that both the clinic and every location where hair-transplant surgery is carried out should be registered with the Care Quality Commission. Scotland, Wales and Northern Ireland have their own regulators.

The Care Quality Commission regulates health and social-care services in England. Registration provides an important layer of oversight, but it is not a guarantee of a particular result. Check the named provider, the actual premises and the scope of regulated activity, then still assess the surgeon’s registration, experience, consent process and outcomes.

Check that the doctor is currently registered and licensed to practise with the General Medical Council, and review any restrictions or conditions. Ask about training and current experience in hair restoration. If someone presents themselves as a specialist plastic surgeon, you can also check the GMC Specialist Register for Plastic Surgery.

No membership can guarantee surgery. Relevant professional membership may indicate engagement with standards, education or a code of conduct, but you should verify the exact membership category and current status. Registration, procedure-specific experience, who performs each surgical step, honest complication data and aftercare remain essential.

Yes. BAHRS, BAPRAS and BAAPS guidance all emphasise meaningful consultation with the doctor or surgeon responsible for treatment—not only a salesperson, broker or clinic manager. The operating clinician should assess you, discuss alternatives and risks, agree the design and give you enough time to decide without pressure.

The patient and responsible doctor should agree the goals, but clinical decisions must be led by the appropriately trained doctor who has examined the scalp and donor. A non-medical adviser should not make a definitive diagnosis, promise a graft count or approve a low hairline without the operating doctor’s assessment.

BAHRS and ISHRS regard FUE donor excisions and recipient-site creation as surgery requiring physician-led judgement. Ask the clinic to name who makes every incision, who extracts grafts, who creates recipient sites and who places grafts. Your consent should match the people and roles present on the day.

Ask for the diagnosis, alternatives, reasons for the proposed method, a measured donor assessment, the surgeon’s experience, who performs each step, scars, realistic density, complication and re-operation policies, aftercare contacts, total cost and what happens if growth is limited. Ask to see comparable, consistently photographed results.

Pause if the doctor is unnamed, the website hides qualifications, a broker controls access, surgery is called scarless or guaranteed, unlimited grafts are promised, a photograph alone produces a fixed plan, discounts expire quickly, a non-refundable deposit is demanded before proper assessment, or aftercare and complication arrangements are vague.

Look beyond the headline price. Verify the doctor, local regulation, insurance, infection and complication arrangements, language and consent, travel timing, aftercare once home and the cost of returning. BAAPS warns that normal travel insurance may not cover elective-surgery complications and local follow-up can be difficult after returning to the UK.

FUE means follicular unit excision. Individual follicular units are removed through small circular donor wounds, usually from the back and sides of the scalp, and transplanted into prepared recipient sites. The older term ‘extraction’ understates that this is surgery involving incisions, permanent tissue removal and clinical judgement.

FUT commonly refers to strip harvesting, also called linear strip excision. A narrow strip of hair-bearing scalp is removed, the donor wound is closed with sutures or staples, and the strip is dissected into follicular-unit grafts. It leaves a permanent linear scar and can provide a substantial graft yield in selected patients.

Neither method is automatically better. FUE avoids a linear scar but creates many small round scars and can overthin the donor if poorly planned. FUT creates a linear scar and usually involves a longer donor recovery, but may preserve broader donor options or provide useful yield. Choice should be individual.

DHI is usually a marketing name for graft placement with an implanter pen; it does not create a third donor-harvest method. Grafts still need to be obtained by FUE or FUT. Ask who creates the recipient sites, how direction and density are controlled, and whether the label changes anything clinically meaningful for you.

Robotic or motorised devices can assist parts of FUE, but a device does not diagnose hair loss, select a safe lifetime graft budget or design a natural result. Outcomes still depend on patient anatomy, operator judgement, settings, graft handling and the surgeon-led plan. Technology should be explained without being presented as a guarantee.

No. Each FUE excision heals with a small permanent scar. With conservative, well-distributed harvesting these may be difficult to see at a suitable hair length, but visibility varies with punch size, skin contrast, healing, extraction pattern and haircut. Very short shaving may reveal a dotted or thinned appearance.

FUT always creates a permanent linear donor scar, but its final width and visibility vary with surgical technique, wound tension, scalp laxity, healing, repeat surgery and hair length. It is often concealed by longer hair, but an unfavourable or stretched scar can remain visible and may need camouflage or revision.

Most FUE procedures involve shaving at least the donor area so extraction can be controlled, though partial or unshaven approaches may suit selected smaller cases. FUT may avoid broad donor shaving because the strip is removed beneath surrounding hair. Recipient-area shaving depends on the plan, existing hair and surgeon.

It is the part of the scalp thought most likely to retain hair long term in pattern hair loss. Its borders are not identical for everyone and should be assessed for density and miniaturisation. Harvesting too close to unstable edges can produce grafts that thin later and expose scars.

Overharvesting removes too many follicles, extracts them unevenly or takes them from an area that cannot tolerate the loss. It may leave permanent patchiness, visible scarring and too little reserve for future treatment. Because removed FUE follicles do not grow back in the donor, prevention is far better than attempted repair.

They can be used at different stages in selected patients, but each procedure changes the donor and reduces future options. Repeat surgery requires reassessment of density, miniaturisation, scars, scalp laxity, healing and total lifetime demand. A previous procedure is never proof that the same method or graft number remains safe.

A graft is a follicular unit that may contain one, two, three or occasionally more hairs. Therefore 2,000 grafts does not mean 2,000 hairs. The mix matters: single-hair grafts are valuable at a soft hairline edge, while larger units can contribute visual density behind it.

There is no responsible universal figure. The area, existing density, hair calibre and curl, scalp-to-hair colour contrast, target design, donor capacity, future loss and whether treatment is staged all affect the range. A final plan needs direct examination and should not be based only on a front-facing photograph.

Graft counting is useful for planning, but price alone can reward a larger number rather than a safer plan. Counts can also be described inconsistently. Ask how grafts are counted, how many hairs they contain, why that number is appropriate, and whether the donor remains acceptable after extraction.

No responsible clinic should guarantee density or graft survival. Visual fullness depends on growth, shaft calibre, curl, contrast, placement, lighting, hairstyle and native hair. Safe recipient spacing is also limited by scalp blood supply. The aim is a realistic improvement within biological and donor constraints—not original childhood density.

A transplant redistributes follicles; it does not replenish them. Follicles removed by FUE are gone from those donor points, while FUT removes a strip containing follicles. Future hair loss, scars and possible revision must all be budgeted from the same limited supply, so the first procedure should preserve options.

The surgeon considers facial proportions, age, existing pattern, forehead height, temples, profile, hair calibre, curl, contrast and future recession. A natural transition usually uses fine single-hair grafts, controlled irregularity and low angles, with visual density increasing behind the edge rather than forming a sharp line.

The crown spreads around a whorl and is viewed under overhead light, so it can consume many grafts without appearing fully dense. Its borders may also expand as loss progresses. Crown work must preserve the whorl direction, avoid a plug-like circle and balance demand against frontal priorities and donor reserve.

They can support an initial discussion, but they cannot measure every feature needed for a final plan. Hair length, lighting and camera angle can conceal miniaturisation or donor depletion. Digital simulations are communication tools, not predictions of growth, density, texture, symmetry or satisfaction.

Local-anaesthetic injections can sting briefly, while the scalp should then be numb for the surgical steps. Pressure, pulling or vibration may still be felt. Tenderness afterwards varies and FUT can be more uncomfortable in the donor area. ‘Pain-free’ is not a responsible guarantee; comfort and pain relief should be discussed.

Hair transplantation is commonly performed under local anaesthetic, sometimes with additional oral or other sedation after medical assessment. The exact approach varies. Tell the clinic about allergies, medicines, sleep apnoea and previous anaesthetic problems, and ask who administers sedation and how you will travel home safely.

It depends on method, graft range, donor complexity, team and breaks. Many procedures occupy much of a day; larger or repair cases may be staged. Speed is not the main quality measure—safe anaesthetic dosing, careful harvesting, graft hydration and time outside the body, recipient design and team fatigue all matter.

Usually yes under local anaesthetic, although some clinics use sedation. Patients may listen to music, watch a screen or rest during appropriate parts of the day. If sedation is planned, follow fasting and escort instructions exactly and do not drive or make important decisions until the clinical team says it is safe.

Do not stop prescribed medicine—especially blood thinners—without instructions from the surgical team and the relevant prescriber. Provide a complete list of prescriptions, non-prescription products and supplements. The clinic should give individual written guidance because stopping a medicine can be more dangerous than continuing it.

Not necessarily. Practice varies according to the procedure, patient factors, local policy and antimicrobial stewardship. Antibiotics do not replace sterile technique and should not be taken from a previous prescription. Use only medicines prescribed for your case and report allergy symptoms or significant side effects promptly.

Follow the written protocol from your own surgical team because timing and products vary. Early washing is normally gentle and designed to avoid rubbing or direct pressure on grafts while keeping the scalp clean. Do not copy forceful online demonstrations or pick crusts before your clinic says it is safe.

Your clinic may advise an elevated or modified position for the first nights to reduce swelling and accidental contact, depending on the treated area. Keep the recipient area away from pillows and pets, use clean bedding and follow the specific duration provided. Seek advice if swelling is marked or involves visual symptoms.

That depends on the procedure, visibility of shaving and crusting, swelling, the physical demands of work and how private you want recovery to be. Desk work may be possible sooner than dusty, hot or strenuous work. Plan time off with your surgeon rather than relying on a one-size-fits-all promise.

These activities create different risks from sweating, friction, pressure, contamination or trauma, so the timetable should come from your operating team. Do not assume all exercise or headwear is equivalent. Ask for staged written guidance and contact the clinic before restarting anything that rubs the donor or recipient area.

Yes, the visible shafts commonly shed during the first weeks while the follicles remain beneath the skin. This can look alarming but is usually part of the expected cycle. Shedding of nearby native hair can also occur. Contact the clinic if there is worsening pain, discharge or another unexpected change.

Early growth often begins after several months and may be uneven, fine, curly or difficult to style at first. Different follicles enter growth at different times. Photographs taken in the early months are not a reliable measure of final density, and crown growth may appear slower than frontal growth.

The NHS notes that a full result may take around 10 to 18 months. Calibre, length, texture and coverage continue to mature, and the crown can take longer to look settled. Your clinic should define when formal review occurs and how it assesses growth consistently.

Follicles selected from a stable donor area can retain their donor characteristics for many years, but ‘permanent’ should not mean guaranteed. Not every graft survives, donor hair can change with age or disease, and surrounding native hair may continue to miniaturise. Long-term appearance therefore depends on the whole plan.

Yes. Surgery does not switch off androgenetic alopecia or another ongoing cause. Loss behind or between grafts can make a once-connected result look isolated. Medical management may be discussed when appropriate, but it has its own benefits, limitations and risks and must be reviewed individually.

Shock loss is temporary shedding that can affect transplanted shafts or nearby native and donor hair after surgery. Vulnerable miniaturised hair may not always recover fully. The risk is one reason to diagnose and stabilise loss where possible, plan recipient sites carefully and discuss alternatives before operating through existing hair.

Risks include pain, swelling, bleeding, infection, folliculitis, cysts, scarring, altered sensation, poor or uneven growth, shock loss, donor thinning, unnatural direction or design, asymmetry, pitting or ridging, medicine or anaesthetic reactions and dissatisfaction. Rare serious complications can occur, and no surgery is risk-free.

Contact the surgical team promptly for severe or increasing pain, active bleeding, spreading redness, pus or offensive discharge, fever, marked swelling, visual symptoms, breathing difficulty, a significant allergic reaction or unexpected deterioration. For a medical emergency call 999 or attend emergency care; do not wait for an email reply.

Growth should be assessed after adequate maturation using comparable photographs and examination. The clinic should review possible causes, the pattern and extent, native-hair change and donor options. A top-up is not automatically safe or owed; any revision needs a fresh diagnosis, risk discussion, written policy and realistic benefit.

Temporary altered sensation, itching or tightness can occur as donor and recipient areas heal. Recovery varies and can be longer after a linear incision. Persistent, severe or worsening symptoms deserve clinical review to exclude infection, nerve irritation, wound problems, dermatitis or another cause rather than being dismissed as ‘normal’.

It places follicular-unit grafts into the frontal scalp to rebuild or reshape the visible transition between forehead and hair. The operation is not simply drawing a lower line: position, temporal junctions, single-hair selection, angle, irregularity, facial proportions and possible future recession all determine whether it looks believable.

It may be possible when the hairline is stable, the scalp is healthy and donor supply can support the area. Lowering increases the surface that needs coverage, so an aggressive design can consume many grafts. Forehead-reduction surgery is a separate operation with different scars, recovery and suitability.

A soft edge commonly uses carefully selected single-hair grafts, natural spacing, low angles and controlled irregularity, while density builds behind it. Multi-hair units, upright direction, excessive symmetry or a ruler-straight border can look artificial. Design should also work in profile and three-quarter views.

It can form part of an individualised plan for trans, non-binary and other patients seeking a different facial frame. The design should follow the patient’s own goals, anatomy, hairstyle, donor capacity, hormones and future hair-loss biology—not a rigid masculine or feminine template. Respectful language and consent are essential.

It transplants grafts into the vertex or crown, usually recreating the local whorl and radiating direction. Crown restoration can improve coverage but rarely reproduces original density. Diagnosis and progression are important because the thinning zone may enlarge beyond the transplanted centre over time.

The crown is a broad curved surface with hairs changing direction around a whorl, and it is exposed to overhead light. Covering a large area at safe spacing can use a substantial donor budget. For some patients, preserving grafts for the frontal frame or staging crown work is the more durable plan.

The surgical principles are similar, but the diagnosis and distribution of loss often differ. Women may have diffuse thinning, hormonal or nutritional contributors, traction, scarring disorders or postpartum shedding. Donor miniaturisation must be excluded, and shaving, hairstyle, future loss and the risk of shock loss need tailored planning.

Sometimes, but diffuse thinning can also involve the donor, leaving no stable supply. Surgery through extensive miniaturised native hair may produce limited visual gain or trigger shock loss. Magnified donor examination and investigation of reversible causes are essential; some patients are better served by medical or cosmetic options.

Postpartum shedding is often telogen effluvium and may recover with time, so transplantation is usually not the first step. Persistent loss should be assessed for pattern hair loss, iron or thyroid issues and other causes. A stable diagnosis and pattern are needed before considering an irreversible procedure.

Not always. FUT or selected partial-shave or unshaven FUE approaches may preserve surrounding length, but suitability depends on graft number, donor access, efficiency and the surgeon’s method. Avoiding visible shaving should not compromise safe harvesting, graft quality or the ability to work accurately around existing hair.

It may be considered only when traction has stopped, the pattern is stable and there is no active inflammation or scarring disorder. Continued tight hairstyles can damage native and transplanted hair. Long-standing scarred areas may have less predictable blood supply, so conservative density or a test session may be advised.

It moves follicular-unit grafts—usually from the scalp—to selected beard, moustache or sideburn areas. It may address congenital sparsity, asymmetry or some stable scars. Natural results rely on very shallow local angles, appropriate density and careful transitions; it cannot guarantee a particular beard style or uniform growth.

Scalp hair is commonly used because it is usually the most practical stable donor. The surgeon should choose hair with a suitable calibre, colour and curl and explain any mismatch. Existing beard hair can sometimes contribute to selected plans, but removing it also creates facial donor scars.

It generally retains scalp-donor characteristics, including growth rate and texture, though it may adapt somewhat in appearance over time. It may need regular trimming and can differ from native beard hair. A careful consultation should compare calibre, curl and colour before committing to a large area.

Yes once the recipient skin has healed and the clinical team says shaving will not disturb crusts or early graft healing. The exact timing and whether to begin with an electric trimmer or another method should come from your surgeon. Transplanted hairs can then be cut or shaved like other hair.

Yes. Recipient sites are tiny but permanent skin injuries, and the donor method creates either many FUE scars or a FUT linear scar. Pigment change, bumps, pitting, cobblestoning or visible direction errors are possible, especially when grafts are placed too deeply, densely or at the wrong angle.

It places carefully selected follicular units—usually fine single hairs from the scalp—into the eyebrow. The plan must respect the changing direction, angle and density across the head, body and tail. Overly upright or multi-hair grafts are difficult to disguise in this small, visible area.

Often yes. Scalp donor hair usually retains a faster and longer growth pattern than native eyebrow hair, so regular trimming and grooming may be needed indefinitely. Curl and calibre mismatch should be discussed before surgery, and hairs can initially grow in an awkward direction before they gain length.

In selected patients, non-scalp follicles may supplement a depleted scalp donor or help camouflage scars. Beard hair often provides more calibre than chest or limb hair, but all non-scalp sources differ in texture, growth cycle, length and extraction scarring. They are usually adjuncts—not an unlimited replacement for scalp donor.

Body-hair extraction and growth can be less predictable, and the eventual texture may not blend well. A limited test can help assess wound healing, scarring, extraction success and recipient growth before committing to a larger procedure. Even a successful test cannot guarantee every later graft will behave identically.

Scalp micropigmentation, or SMP, places pigment into the scalp to imitate the appearance of closely cut follicles or reduce contrast through thinning hair and scars. It is a visual camouflage treatment, not a hair transplant. Design, pigment choice, dot size, depth and future hair loss all affect how natural it looks.

SMP does not create follicles or stimulate growth. Pigment can remain for years but commonly softens or fades and may change as skin, sun exposure, hair colour and loss evolve. ‘Permanent’ and ‘temporary’ can both be misleading; ask about pigment, expected fading, maintenance and removal limitations.

SMP is often built over more than one session so colour and density can be assessed as the skin heals. The number and interval depend on the area, skin, scar tissue, desired effect and response to pigment. A conservative first pass is safer than making the hairline too dark or solid.

Risks include infection, allergic or inflammatory reaction, pigment migration, colour change, uneven fading, scarring, an unnatural hairline or dots, and dissatisfaction. Scar tissue may retain pigment differently. Use a properly trained practitioner with appropriate hygiene, consent, patch-testing policy and realistic healed examples.

Options may include surgical revision, FUE grafting into or around the scar, SMP, hairstyle changes or a combination. The right choice depends on scar type, width, position, tension, scalp laxity, blood supply, available donor and desired haircut. Each option adds its own scars and uncertainty.

Sometimes. Mature, healthy scars can accept grafts, but altered blood supply and tissue stiffness make growth less predictable than normal scalp. Density may need to be conservative and staged, and a test area can be useful. Active inflammatory disease, unstable scars or poor vascularity may make grafting unsuitable.

No treatment can promise to erase a scar. Excision replaces it with another scar and recurrence or widening can occur; grafting and SMP camouflage rather than remove it. A useful consultation defines the realistic goal—narrower, less contrasting or easier to conceal—and explains what cannot be corrected.

Forehead reduction, or hairline lowering, advances the existing hair-bearing scalp after removing a strip of forehead skin. It is not a hair transplant. It creates an incision scar along the new hairline and depends on scalp laxity, hairline stability, anatomy, medical suitability and acceptance of surgical risks.

Forehead reduction moves the existing hairline in one operation and can produce immediate lowering, but it creates a longer hairline scar and may not suit progressive loss. Transplantation adds follicles without moving the scalp but requires donor grafts and slow growth. Some patients may be unsuitable for either or need a combined plan.

Low-level light therapy, often called LLLT or photobiomodulation, uses red or near-infrared light from a cap, helmet, comb or clinic device. Some people with pattern hair loss may see a modest improvement in shedding or density, but device quality, dose and response vary and it does not replace diagnosis.

No. Hair-removal lasers use different energy and targets to damage follicles. LLLT uses lower-energy light with the aim of influencing follicle activity without heating or destroying tissue. Confusing the two creates unrealistic expectations; always check the exact device, indication, regulatory status and proposed protocol.

No. Evidence suggests possible benefit for selected pattern hair loss, but the average change is usually modest and individuals respond differently. It will not create new follicles in a smooth scar or fully bald area. Claims of guaranteed regrowth, instant results or a permanent cure should be treated cautiously.

Protocols differ by device, wavelength, power, coverage and manufacturer instructions, so there is no universal schedule. Convenience can favour home use, while a clinic may offer supervised equipment and review. Compare the actual device and evidence—not simply ‘medical grade’ language—and avoid exceeding instructions.

It may be used as an adjunct before or after surgery when the clinical team considers it appropriate, but it cannot guarantee graft survival. Any benefit to native hair may require ongoing use and can diminish after stopping. Timing around surgery should follow the operating surgeon’s written instructions.

Depending on diagnosis, options can include licensed or off-label medicines, correction of a deficiency or medical trigger, PRP, LLLT, camouflage fibres, SMP, hair systems and hairstyle changes. Benefits, contraindications and evidence vary. Medicines and injections require individual medical review; supplements are not harmless substitutes for diagnosis.

The current guide starts at £4,000 for a small procedure under 1,000 grafts, £5,000 for a medium 1,000–1,500-graft procedure and £6,000 for a large 1,500–2,000-plus-graft procedure. These are starting prices; assessment confirms suitability, graft range, technique and the written quotation.

It should be. Precision Hair Clinic’s guide prices are not the final personal quote. After assessment, the clinic should confirm the agreed procedure and fee in writing before you decide. Check what is included, cancellation and refund terms, medicines, follow-up, revision policy and any circumstances that could create extra cost.

The redesigned pricing structure uses small, medium and large procedure-size bands rather than a running per-graft multiplier. The treatment plan should still state a responsible graft range, but the clinical recommendation should not be driven by adding billable grafts. Your assessment and quotation confirm the applicable band.

The current pricing page describes 0% finance for up to 12 months. Finance is subject to status, affordability, eligibility, lender approval and applicable terms. It should never be used to rush a decision; review the total amount, monthly payment, cancellation terms and treatment plan before applying.

An online discussion can review your concerns, history and photographs and explain possible next steps. It cannot replace hands-on scalp and donor examination when that is needed for final diagnosis, graft planning or consent. The clinic should clearly distinguish an initial estimate from a confirmed surgical plan.

Provide clear, recent photographs in consistent light: front, both temples, top, crown, sides and back donor area, with dry hair parted where possible. Include age, onset and rate of change, symptoms, diagnoses, medicines, medical history, family pattern, previous treatment or surgery and the outcome you hope to discuss.

Precision Hair Clinic is at Fence House, 84 Buxton Road, Macclesfield, Cheshire SK10 1JS. Call 0333 303 4870 or email info@pmclinic.co.uk. Existing patients with a postoperative concern should use the clinical contact instructions they were given; emergencies require 999 or urgent medical care.